Holistic Oncology 1 and 2 

In March 2017 Chanchal Cabrera presented a 2 day seminar at Middlesex University, London (UK)  entitled Holistic Oncology 1. This was followed by Holistic Oncology 2 in November 2017.

If you would like to access to the edited recordings and notes from this seminar, you can do so for a fee of £25.00. per program

Just click on the course link, at https://heartwood-uk.net/lms/course/view.php?id=42 where you will be asked to pay the fee using our secure Stripe payment gateway. You will get access to the course immediately your payment is received. We do not receive your card details at any point in the payment process, and Stripe will only store them if you ask them to remember your card.

HOLISTIC ONCOLOGY – A PHYTOTHERAPY PERSPECTIVE
Chanchal Cabrera MSc, FNIMH, RH(AHG)

Part 1 – Course Overview

  • What cancer is, how it starts, how it progresses, what goes wrong and what can be done to counteract the aberrant cell behaviors
  • Cancer prevention and immune building protocols
  • Why the liver is so important and how to support it
  • Stress, Liver and the Immune system in cancer – materia medica for building the foundation
  • (Adaptogens, alteratives and immune tonics)
  • How to read blood work and pathology reports, what other ways of testing are open to herbalists and how to assess the cancer patient.

Day One

  • Understanding the biomechanics of cancer – pathophysiology, disease initiation and progression

Day Two and Day Three

  • Assessing the cancer patient and specific treatment planning
    Individualizing the protocols – treatment planning: tests and assessments, stabilizing DNA, modulating
  • Growth factors, anti-angiogenesis, strengthening connective tissue, normalizing hormones

Learning Objectives

After completion of Holistic Oncology part 1 the student shall be able to

  • Recognize and mitigate exogenous risk factors for cancer – diet, environment, stress
  • Assess for and clinically control for endogenous risk factors for cancer – glycation, oxidative stress load, detoxification pathways, coagulopathies
  • Assess for and clinically control co-morbidities and symptoms of cancer
  • Create a comprehensive foundation treatment plan for a cancer patient, taking into account their unique oncologic typology

Part 2 – Course Overview

Building on the depth and detail of level one, this two day intensive will give practical guidelines and protocols for managing cases.

  • Coping with chemo
  • Immunotherapies
  • Genetic screening in cancer therapies
  • Materia Medica for cancer – the cyto-toxic herbs

Day Four

  • Chemotherapy statistics of success
  • End points of treatment
  • Labs and access to testing
  • 6 core mechanisms of chemo
  • Administration of chemo – chronotherapy and metronomic therapy
  • Melatonin and sleep
  • Blood Brain Barrier – Ultrasound, amytryptaline, liposomes
  • Fasting and alternate day feeding
  • Mouth sores, poor appetite, weight loss, fatigue, constipation, nausea & vomiting, diarrhoea
  • Herbal teas for digestion
  • Supplements for cancer
  • Neuropathy
  • Mucositis
  • Safety of herbs and supplements with chemo

Types of Chemo and predictive testing

  • Anthracyclins
  • Platinums
  • Taxanes

Targeted therapies / gene guided therapies Immunotherapies

  • Monoclonal Antibodies – Protein tyrosine kinase receptors
  • Tyrosine Kinase Inhibitors – Protein kinase C receptors
  • Managing the interferon response – Immune mediators and modulators, fever treatment
  • Skin rash

New drugs in cancer:

  • Paclocilib as a reversible inhibitor of cyclin -dependent kinases (CDK) 4 and
  • Chimeric antigen receptor (CAR) T cells
  • Non‐standard Drugs Useful in Integrative Cancer Therapies
    ~       Celebrex (<COX‐2) 200‐400 mg.
    ~       Valproic acid (<HDA) 500‐750 mg.
    ~       Rapamycin (<PI3K, mTOR) 25 ‐ 100 mg.
    ~       Heparin (<PAI‐1) Low molecular weight
    ~       Low Dose Naltrexone (Opioid receptor antagonist) 4.5 mg.
    ~       Noscapine (opium alkaloid) 100‐500 mg.
    ~       Disulfiram (multi anti‐cancer mechanisms) 125‐250 mg.
    ~       Tetrathiomolybdate(TM) (copper chelator) 60‐120 mg.
    ~       Cimetidine (<H2) 400‐800 mg.
    ~       DCA
  • Photo Dynamic Therapy (PDT)

Day Five

Materia medica for cancer – managing Doses of Cytotoxics
Asimina triloba
Artemisia annua
Camptotheca acuminata
Chelidonium majus
Larrea divaricata
Phytolacca decandra
Thuja occidentalis
Podophyllum peltatum
Taxus sp.
Vinca rosea
Viscum album
Corydalis ambigua
Camellia sinensis
Curcuma longa

Comments are closed.